Trio of new drugs from Abbott shows high cure rate for hepatitis C. |
![]() |
Reuters: A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had previously failed to benefit from standard treatment, as well as very high cure rates for newly treated patients, Abbott said on Saturday. |